More on SPRY

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+8.7% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/12/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

ARS Pharmaceuticals (NQ:SPRY)
Delayed: 8.99 +0.24 (2.74%)
Prev. Close $8.75  
Open$8.91 
52 Wk High$ 
52 Wk Low$ 
Day High$9.13 
Day Low$8.81 
P/E N/A  
EPS$ 
Volume455,460 

Friends, Peers and Foes (?): ALK-B (more...)

Jun 4, 2026 08:00 AM Drew Brees Collaborates with ARS Pharmaceuticals to Raise Awareness About Living Life with Severe Allergies
Jun 1, 2026 04:42 PM Form 3 ARS Pharmaceuticals, For: Jun 01 Filed by: Casale Donn
May 29, 2026 07:00 AM ARS Pharmaceuticals Inc (SPRY) PT Raised to $30 at Cantor Fitzgerald
May 15, 2026 04:15 PM Form SCHEDULE 13G/A ARS Pharmaceuticals, Filed by: Rubric Capital Management LP
May 15, 2026 06:33 AM Form 10-Q ARS Pharmaceuticals, For: Mar 31
May 15, 2026 06:29 AM Form 8-K ARS Pharmaceuticals, For: May 15
May 15, 2026 06:01 AM ARS Pharmaceuticals, Inc. (SPRY) Misses Q1 EPS by 12c, Beats on Revenue
May 15, 2026 06:00 AM ARS Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Update
May 13, 2026 08:15 AM Form 8-K ARS Pharmaceuticals, For: May 12
May 13, 2026 08:01 AM ARS Pharmaceuticals appoints Donn Casale as president
View All Articles

Entities mentioned with SPRY

View All Entities